Abstract |
In vitro studies of autosomal dominant Alzheimer's disease implicate longer amyloid-β peptides in disease pathogenesis; however, less is known about the behaviour of these mutations in vivo. In this cross-sectional cohort study, we used liquid chromatography-tandem mass spectrometry to analyse 66 plasma samples from individuals who were at risk of inheriting a mutation or were symptomatic. We tested for differences in amyloid-β (Aβ)42:38, Aβ42:40 and Aβ38:40 ratios between presenilin 1 (PSEN1) and amyloid precursor protein (APP) carriers. We examined the relationship between plasma and in vitro models of amyloid-β processing and tested for associations with parental age at onset. Thirty-nine participants were mutation carriers (28 PSEN1 and 11 APP). Age- and sex-adjusted models showed marked differences in plasma amyloid-β between genotypes: higher Aβ42:38 in PSEN1 versus APP (P < 0.001) and non-carriers (P < 0.001); higher Aβ38:40 in APP versus PSEN1 (P < 0.001) and non-carriers (P < 0.001); while Aβ42:40 was higher in both mutation groups compared to non-carriers (both P < 0.001). Amyloid-β profiles were reasonably consistent in plasma and cell lines. Within the PSEN1 group, models demonstrated associations between Aβ42:38, Aβ42:40 and Aβ38:40 ratios and parental age at onset. In vivo differences in amyloid-β processing between PSEN1 and APP carriers provide insights into disease pathophysiology, which can inform therapy development.
|
Authors | Antoinette O'Connor, Josef Pannee, Teresa Poole, Charles Arber, Erik Portelius, Imogen J Swift, Amanda J Heslegrave, Emily Abel, Nanet Willumsen, Helen Rice, Philip S J Weston, Natalie S Ryan, James M Polke, Jennifer M Nicholas, Simon Mead, Selina Wray, Lucía Chávez-Gutiérrez, Chris Frost, Kaj Blennow, Henrik Zetterberg, Nick C Fox |
Journal | Brain : a journal of neurology
(Brain)
Vol. 144
Issue 10
Pg. 2964-2970
(11 29 2021)
ISSN: 1460-2156 [Electronic] England |
PMID | 33892504
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain. |
Chemical References |
- Amyloid beta-Peptides
- Biomarkers
- PSEN1 protein, human
- Presenilin-1
|
Topics |
- Adult
- Alzheimer Disease
(blood, diagnosis, genetics)
- Amyloid beta-Peptides
(blood, genetics)
- Biomarkers
(blood)
- Cohort Studies
- Cross-Sectional Studies
- Female
- Genotype
- Humans
- Induced Pluripotent Stem Cells
(metabolism)
- Longitudinal Studies
- Male
- Middle Aged
- Presenilin-1
(blood, genetics)
|